by Clinical Neuropsychologist | Wednesday, January 8, 2025 | Dementia
Abstract INTRODUCTION We investigated the specific factors driving abnormal angiogenesis in Alzheimer’s disease (AD) and its role in cerebrovascular lesions and neurodegeneration. METHODS We assessed cerebrovascular pathologies, amyloid-beta (Aβ), and tau...
by Clinical Neuropsychologist | Wednesday, January 8, 2025 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Timothy Daly, Kasper P. Kepp, Bruno P. Imbimbo | January 8,...
by Clinical Neuropsychologist | Wednesday, January 8, 2025 | Dementia
Abstract INTRODUCTION The importance of protein amyloidogenesis, associated with various diseases and functional roles, has driven the creation of computational predictors of amyloidogenicity. The accuracy of these predictors, particularly those utilizing artificial...
by Clinical Neuropsychologist | Wednesday, January 8, 2025 | Dementia
Abstract INTRODUCTION Sarcopenia, with its complex diagnostic process, is a likely independent predictor of poor prognosis in patients with Alzheimer’s disease (AD). However, research on the clinical characteristics and biomarkers of AD patients with sarcopenia...
by Clinical Neuropsychologist | Wednesday, January 8, 2025 | Dementia
Abstract INTRODUCTION Amyloid beta (Aβ) plaques and hyperphosphorylated tau in the entorhinal regions are key Alzheimer’s disease (AD) markers, but the spatial Aβ pathways influencing tau pathology remain unclear. METHODS We applied predictive modeling to...
